Incidence, Timing, and Management of Infections in Patients Receiving Daratumumab for the Treatment of Newly Diagnosed Transplant-Ineligible Multiple Myeloma in the MAIA Study

被引：0

作者：

Bahlis, Nizar J. ^{[1
]}

Facon, Thierry ^{[2
,3
]}

Usmani, Saad ^{[4
]}

Moreau, Philippe ^{[5
]}

Raje, Noopur ^{[6
]}

Zweegman, Sonja ^{[7
]}

Chari, Ajai ^{[8
]}

Perrot, Aurore ^{[9
]}

Manier, Salomon ^{[10
]}

Orlowski, Robert ^{[11
]}

Goldschmidt, Hartmut ^{[12
]}

Basu, Supratik ^{[13
,14
]}

Hulin, Cyrille ^{[15
]}

Weisel, Katja ^{[16
]}

Mohty, Mohamad ^{[17
,18
]}

Plesner, Torben ^{[19
,20
]}

Cook, Gordon ^{[21
]}

Leleu, Xavier ^{[22
]}

Quach, Hang ^{[23
]}

Venner, Christopher P. ^{[24
]}

Ngo, Mai ^{[25
]}

Bolyard, Kasey ^{[25
]}

Carson, Robin ^{[25
]}

Borgsten, Fredrik ^{[25
]}

Kumar, Shaji ^{[25
,26
]}

机构：

[1] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[2] Univ Lille, & French Acad Med, Dept Haematol, Paris, France

[3] French Acad Med, Paris, France

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[5] Univ Hosp Hotel Dieu, Dept Hematol, Hotel Dieu, France

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands

[8] Univ Calif San Francisco, San Francisco, CA USA

[9] Ctr Hosp Univ Toulouse, Serv Hematol, Toulouse, France

[10] Univ Lille, Serv Hematol, CHU Lille, Hop Huriez, Lille, France

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[12] Univ Hosp Heidelberg, GMMG Study Grp, Dept Internal Med, Heidelberg, Germany

[13] Royal Wolverhampton NHS Trust, Wolverhampton, W Midlands, England

[14] Wolverhampton Univ, CRN West Midlands, NIHR, Wolverhampton, W Midlands, England

[15] Hop Haut Leveque, Univ Hosp, Dept Hematol, Bordeaux, France

[16] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[17] Sorbonne Univ, Hop St Antoine, Paris, France

[18] INSERM, UMRS938, Paris, France

[19] Vejle Hosp & Univ Southern Denmark, Vejle, Denmark

[20] Univ Southern Denmark, Odense, Denmark

[21] Univ Leeds, Leeds Inst Clin Trials Res, Canc Res UK Clin Trials Unit, Leeds, W Yorkshire, England

[22] CHU Poitiers, Hematol, PRC, Poitiers, France

[23] Univ Melbourne, St Vincents Hosp Melbourne, Melbourne, Vic, Australia

[24] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[25] Janssen Res Dev LLC, Lower Gwynedd Township, PA USA

[26] Mayo Clin, Rochester, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-324

引用

页码：S221 / S221

页数：1

共 50 条

[21] Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Facon, Thierry
Venner, Christopher P.
Bahlis, Nizar J.
Offner, Fritz
White, Darrell J.
Karlin, Lionel
Benboubker, Lotfi
Rigaudeau, Sophie
Rodon, Philippe
Voog, Eric
Yoon, Sung-Soo
Suzuki, Kenshi
Shibayama, Hirohiko
Zhang, Xiaoquan
Twumasi-Ankrah, Philip
Yung, Godwin
Rifkin, Robert M.
Moreau, Philippe
Lonial, Sagar
Kumar, Shaji K.
Richardson, Paul G.
Rajkumar, S. Vincent
BLOOD, 2021, 137 (26) : 3616 - 3628
[22] Efficacy of Daratumumab, Lenalidomide, and Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma and Impaired Renal Function from the Phase 3 Maia Study Based on Lenalidomide Starting Dose
Usmani, Saad Z.
Kumar, Shaji
Plesner, Torben
Orlowski, Robert Z.
Moreau, Philippe
Bahlis, Nizar J.
Basu, Supratik
Nahi, Hareth
Hulin, Cyrille
Quach, Hang
Goldschmidt, Hartmut
O'Dwyer, Michael E.
Perrot, Aurore
Venner, Chris P.
Weisel, Katja
Mace, Joseph R.
Raje, Noopur S.
Tiab, Mourad
Macro, Margaret
Frenzel, Laurent
Leleu, Xavier
Pei, Huiling
Van Rampelbergh, Rian
Tromp, Brenda
Delioukina, Maria
Facon, Thierry
BLOOD, 2021, 138
[23] Management of newly diagnosed transplant ineligible multiple myeloma
Atrash, Shebli
Bhutani, Manisha
Paul, Barry
Voorhees, Peter M.
Usmani, Saad Z.
LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2549 - 2560
[24] Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma
Fonseca, Rafael
Facon, Thierry
Hashim, Mahmoud
Nair, Sandhya
He, Jianming
Ammann, Eric
Lam, Annette
Wildgust, Mark
Kumar, Shaji
ONCOLOGIST, 2023, 28 (05): : E263 - E269
[25] Impact of age on efficacy and safety of daratumumab in combination with lenalidomide and dexamethasone (D-Rd) in patients (pts) with transplant-ineligible newly diagnosed multiple myeloma (NDMM): MAIA.
Usmani, Saad Zafar
Facon, Thierry
Kumar, Shaji
Plesner, Torben
Moreau, Philippe
Basu, Supratik
Nahi, Hareth
Macro, Margaret
Quach, Hang
Perrot, Aurore
Venner, Chris
Weisel, Katja
Raje, Noopur S.
Attal, Michel
Leleu, Xavier
Krevvata, Maria
Wang, Jianping
Kobos, Rachel
Hulin, Cyrille
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[26] Initial treatment of transplant-ineligible patients in multiple myeloma
Mateos, Maria-Victoria
Leleu, Xavier
Palumbo, Antonio
San Miguel, Jesus-F
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 67 - 77
[27] Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews
Visacri, Manlia Berlofa
Ribeiro, Mayra Carvalho
Komoda, Denis Satoshi
Duarte, Bruno Kosa Lino
Correa, Carlos Roberto Silveira
Maia, Flavia de Oliveira Motta
Alves, Daniela Fernanda dos Santos
VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
[28] Daratumumab plus Bortezomib/Lenalidomide/ Dexamethasone in Patients With Transplant-ineligible or Transplant-deferred Newly Diagnosed Multiple Myeloma: Results of the Phase 3 CEPHEUS Study
Usmani, Saad Z.
Facon, Thierry
Hungria, Vania
Bahlis, Nizar J.
Venner, Christopher P.
Braunstein, Marc
Pour, Ludek
Marti, Josep
Basu, Supratik
Cohen, Yael C.
Matsumoto, Morio
Suzuki, Kenshi
Hulin, Cyrille
Grosicki, Sebastian
Legiec, Wojciech
Beksac, Meral
Maiolino, Angelo
Liu, Weiping
Wang, Jianping
Krevvata, Maria
Lopez-Masi, Lorena
Carey, Jodi
Rowe, Melissa
Carson, Robin
Zweegman, Sonja
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S288 - S289
[29] Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma
Facon, Thierry
Lee, Jae Hoon
Moreau, Philippe
Niesvizky, Ruben
Dimopoulos, Meletios
Hajek, Roman
Pour, Ludek
Jurczyszyn, Artur
Qiu, Lugui
Klippel, Zandra
Zahlten-Kumeli, Anita
Osman, Muhtarjan
Paiva, Bruno
San-Miguel, Jesus
BLOOD, 2019, 133 (18) : 1953 - 1963
[30] Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
Rafae, Abdul
Ehsan, Hamid
Wahab, Ahsan
Khan, Sana Irfan
Khan, Israr
Ashraf, Sara
Ali, Sundas
Khalid, Farhan
Neupane, Karun
Valent, Jason
Khouri, Jack
Samaras, Christy
Mazzoni, Sandra
Anwer, Faiz
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176

← 1 2 3 4 5 →